|
Volumn 53, Issue 1, 2010, Pages 153-154
|
Avoid a different standard of care when applying results of development of antiretroviral therapy in Africa (DART) study
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
AFRICA;
ANTIVIRAL THERAPY;
CLINICAL ASSESSMENT;
COST CONTROL;
DEVELOPING COUNTRY;
DIAGNOSTIC TEST;
FINANCIAL MANAGEMENT;
FOLLOW UP;
HEALTH CARE ACCESS;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MEDICAL CARE;
OUTPATIENT DEPARTMENT;
PATIENT COUNSELING;
PATIENT MONITORING;
POPULATION RESEARCH;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
STANDARD;
SURVIVAL RATE;
TREATMENT OUTCOME;
AFRICA;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DEVELOPING COUNTRIES;
DRUG MONITORING;
HEALTH SERVICES ACCESSIBILITY;
HIV INFECTIONS;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 74049156871
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/QAI.0b013e3181c79be7 Document Type: Letter |
Times cited : (1)
|
References (4)
|